Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Evolving Treatment Landscape of R/R HER2+ mBC
May 13, 2020 – 
Typical outcomes for patients who have progressed after 2 lines of therapy in HER2+ metastatic breast cancer and a review of trastuzumab deruxtecan as seen in the DESTINY-Breast01 trial.
Payer Coverage of IV Versus Oral Therapy in mBC
May 13, 2020 – 
A payer perspective on coverage of IV versus oral therapy in metastatic breast cancer taking into consideration cost and patient survival outcomes.
Compliance and Adherence to Therapy in mBC
May 06, 2020 – 
The importance of patient education in managing toxicities on therapy in metastatic breast cancer.
Advantages of Oral Taxanes in mBC
May 06, 2020 – 
A discussion on a phase 3 trial using oral paclitaxel and encequidar for treatment of metastatic breast cancer.
Payer Coverage on Repeat Biopsy in mBC
April 29, 2020 – 
Testing patients who have received CDK4/6 inhibitors in metastatic breast cancer as well as testing patients with ctDNA upon disease progression with a single gene test versus NGS.
Payer Perspective of Coverage on Cancer Therapies
April 29, 2020 – 
The role of PI3 kinase inhibition in various settings in metastatic breast cancer and a payer perspective on differentiating breast cancer at various stages of disease progression.
SOLAR-1 Trial in Metastatic Breast Cancer
April 22, 2020 – 
The SOLAR-1 trial data in the second-line setting in metastatic breast cancer are examined as well as the use of alpelisib and everolimus.
Treatment After Progression on CDK 4/6i in mBC
April 22, 2020 – 
Testing for ESR1 mutations after disease progression in metastatic breast cancer.
Treating COPD With Combination Therapy
March 11, 2020 – 
Implications for treating chronic obstructive pulmonary disease with combination regimens based on clinical data and how the condition will likely be managed in the coming years.
Patient-Reported Outcomes in COPD
March 04, 2020 – 
The role of assessing and measuring patients’ feedback to improve how chronic obstructive pulmonary disease is managed.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.